Early Signs of Liver Cancer You Shouldn't Ignore: An Oncologist's Guide

The early signs of liver cancer are easy to dismiss because they overlap with everyday complaints: persistent fatigue, unexplained weight loss, a dull ache under the right ribs, and a loss of appetite that doesn't have an obvious cause. None of these scream cancer on their own, which is exactly why they're missed until the disease has advanced.

I see this pattern often in the clinic. A patient mentions they've "just been tired" for two months, or that their trousers have gotten looser without trying. Taken individually, these are nothing. Taken together, and persisting for weeks, they're worth an ultrasound and a liver panel, not another round of multivitamins.

This guide covers what those early signs actually look like, who's at higher risk in eastern India specifically, and what the diagnostic and treatment pathway involves once liver cancer is suspected.

What are the early warning signs of liver cancer?

The early signs are typically vague and non-specific, which is precisely why they get overlooked for weeks or months before anyone investigates. Watch for a cluster of the following rather than waiting for one dramatic symptom:

• Unexplained weight loss without a change in diet or activity, often the first thing patients notice in hindsight

• Persistent fatigue that doesn't improve with rest and isn't explained by sleep or stress

• Loss of appetite or feeling full after a small meal, sometimes with mild nausea

• Dull pain or a sense of fullness in the upper right abdomen, occasionally spreading to the right shoulder blade

• Abdominal swelling or bloating that doesn't resolve, which can indicate fluid build-up (ascites)

• Yellowing of the skin or eyes (jaundice), along with dark urine and pale, clay-coloured stools

Any one of these lasting more than two to three weeks deserves a conversation with a doctor. Waiting for pain to become severe means waiting past the point where treatment options are widest.

Why do hepatitis B and C matter so much for liver cancer risk in India?

Chronic hepatitis B and C infection are among the strongest risk factors for liver cancer in India, and both are common enough that screening for them is a genuine early detection tool, not an afterthought. This is a different risk profile from what's typically discussed in Western liver cancer coverage, where alcohol and fatty liver disease dominate.

A recent analysis of cancer patients across India found that liver cancer showed a markedly increased proportional incidence among people with hepatitis B and hepatitis C infection, with incidence ratios of roughly 14 and 7 times higher respectively in men compared with those without the infection. Hepatitis B and C together still account for a substantial share of liver cancer cases diagnosed in the country.

The practical takeaway: if you've ever tested positive for hepatitis B or C, or you're unsure of your status, that alone is a reason to ask your doctor about periodic liver screening, well before any symptoms appear.

What other factors raise your risk?

Beyond viral hepatitis, several other conditions and habits meaningfully increase liver cancer risk, and they're increasingly common alongside the traditional viral causes.

Cirrhosis from any cause, whether viral, alcohol-related, or from fatty liver disease, is the single biggest risk factor, since most liver cancers develop in a liver that's already scarred. Alcohol use disorder, obesity and type 2 diabetes (which drive metabolic dysfunction-associated steatotic liver disease), and a family history of liver cancer all add to that baseline risk.

Exposure to aflatoxins, a toxin produced by mould that can contaminate improperly stored grains and groundnuts, is a less discussed but locally relevant risk factor in parts of India. Long-term exposure combined with hepatitis B infection raises risk more than either factor alone.

How is liver cancer actually diagnosed and staged?

Diagnosis starts with blood tests, imaging, and often a biopsy, in that rough order. An alpha-fetoprotein (AFP) blood test is a common first step, though a normal result doesn't rule out cancer; it's a supporting marker, not a standalone diagnostic.

Imaging does most of the diagnostic work. A triple-phase CT scan or contrast-enhanced MRI can often identify liver cancer with enough confidence that a biopsy isn't always needed, particularly in patients with known cirrhosis. When the picture is unclear, a biopsy confirms the diagnosis directly.

Staging then determines how far the cancer has spread, whether it's confined to the liver, involves nearby blood vessels, or has spread to distant organs, and this stage is what drives every subsequent treatment decision.

What treatment options exist, and why does surgery matter so much?

Treatment depends heavily on how early the cancer is caught, which is the entire reason early signs matter as much as they do. Options generally fall into a few categories, and more than one may be combined.

Surgical and procedural options

• Surgical resection, removing the tumour along with a margin of healthy liver tissue, for patients with good liver function and a tumour confined to one area

• Liver transplant, replacing the whole liver, an option for select early-stage cases, especially where cirrhosis limits how much liver can safely be removed

• Ablation techniques such as radiofrequency or microwave ablation, which destroy small tumours without full surgery, are often used when a patient isn't a surgical candidate

• Transarterial chemoembolisation (TACE), which delivers chemotherapy directly into the tumour's blood supply while blocking it, typically for intermediate-stage disease

• Systemic therapy, including targeted drugs and immunotherapy, for cancer that has spread beyond the liver

Why the stage at diagnosis matters this much: the American Cancer Society reports a five-year relative survival rate of 37.6% for liver cancer caught at a localised stage, compared with just 3.5% once it has spread to distant parts of the body. That gap is almost entirely a function of how early the disease is found, which is the whole argument for taking vague symptoms seriously rather than waiting them out.

If you have any combination of the symptoms above and a known risk factor, a single consultation and a liver panel is a small ask against what early detection can change.

Where can patients in eastern India access liver cancer surgery and care?

Ruby General Hospital brings together surgical oncology, gastroenterology and medical oncology under one roof, which matters for liver cancer specifically because the diagnostic pathway, imaging, hepatology assessment and biopsy need to move quickly into a treatment decision without the patient being referred between separate centres.

For families researching a cancer surgery hospital in Kolkata after a suspicious scan or an abnormal liver test, that consolidation of hepatology and surgical oncology in one building is what shortens the gap between "something's not right" and an actual treatment plan. It's a large part of why Ruby General Hospital comes up repeatedly when patients from across eastern India ask where to go for liver cancer surgery in Kolkata.

If any of the signs in this guide sound familiar, especially alongside a hepatitis history or long-standing liver disease, don't wait for the pain to worsen before acting. Schedule an appointment with a hepatologist or oncologist this week and ask directly what your risk profile and next diagnostic step should be.